Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis
about
Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome AnalysisPlatelet Interaction with Innate Immune CellsMacrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on AtherosclerosisAntioxidants, inflammation and cardiovascular diseaseComputer-based prediction of the drug proarrhythmic effect: problems, issues, known and suspected challengesStructural basis for the sheddase function of human meprin metalloproteinase at the plasma membraneLong-term supplementation with a cystine-based antioxidant delays loss of muscle mass in agingPhenotypic polarization of macrophages in atherosclerosisAtherogenesis and iron: from epidemiology to cellular level.Platelets and their chemokines in atherosclerosis-clinical applications.Umbilical cord mesenchymal stem cells suppress host rejection: the role of the glycocalyx.Macrophages: plastic solutions to environmental heterogeneity.Protein carbonylation and heat shock proteins in human skeletal muscle: relationships to age and sarcopenia.Structural contributions to fibrillatory rotors in a patient-derived computational model of the atria.Touch of chemokines.Heme oxygenase-1, oxidation, inflammation, and atherosclerosisCXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis.Intimal pericytes as the second line of immune defence in atherosclerosis.Elevated ARG1 expression in primary monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast cancer patientsStem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action.The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential.Novel immune signals and atherosclerosis.Molecular biology of atherosclerosis.The mononuclear phagocyte system in homeostasis and disease: a role for heme oxygenase-1.Clinical significance of macrophage phenotypes in cardiovascular disease.Changes in transcriptome of macrophages in atherosclerosis.Potential scenarios leading to ovarian cancer arising from endometriosis.Small cell lung cancer: Recruitment of macrophages by circulating tumor cells.Protein Thiol Redox Signaling in Monocytes and Macrophages.Steroids Regulate CXCL4 in the Human Endometrium During Menstruation to Enable Efficient Endometrial Repair.Gene editing as applied to prevention of reproductive porcine reproductive and respiratory syndrome.Circulating tumor cell interactions with macrophages: implications for biology and treatment.Plasma protein profiling in patients undergoing coronary artery bypass grafting surgery and clinical significance.Components in Plasma-Derived Factor VIII, But Not in Recombinant Factor VIII Downregulate Anti-Inflammatory Surface Marker CD163 in Human Macrophages through Release of CXCL4 (Platelet Factor 4).Effects of premature anodal stimulations on cardiac transmembrane potential and intracellular calcium distributions computed by anisotropic Bidomain models.CXCL4 is a novel nickel-binding protein and augments nickel allergy.Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice.Dynamic resting state fMRI analysis in mice reveals a set of Quasi-Periodic Patterns and illustrates their relationship with the global signal.Transfusion-related immunomodulation: a reappraisal.FOXO3-dependent apoptosis limits alcohol-induced liver inflammation by promoting infiltrating macrophage differentiation.
P2860
Q26738772-E4C493DB-2506-4B09-8381-782E93B14A81Q26745910-05D9195D-3D66-4304-B8D3-AD8D31ACCFD6Q26780531-0460EBEA-CCFF-4961-AEE0-970D002C5999Q26823009-AD369FFE-43E0-4305-BB30-199D8274AA44Q26861453-C940A7FF-70F0-4B6D-8BE5-C2094F52D3D1Q27673367-2652397C-F70C-423C-B132-C87742A3942CQ28384001-4356DF25-E67B-4633-AC0C-F1055E983889Q30412717-9C3C6DB9-D330-46CC-BDA1-CE7FBA4CF9C9Q33595279-36342978-2753-44FB-B3D1-7E135D6C6F98Q34019069-6D72EBA7-EE48-4A70-B1A5-AE1CCDFBFBD2Q34140907-7B3385DB-04FA-41C1-AFF4-BD3348FB0413Q34358862-D15BB228-5062-4EB6-9C19-F0E79D4EB8DDQ34994117-97D7FC54-19A0-45DF-BB37-5EC6124582A4Q36047482-D0D201AA-C5D8-45AB-9330-64E7A12B4297Q36090029-F11062E8-6BA9-432A-A699-6C4EA69C6BCFQ36103851-84CF6452-2790-4209-AD85-7C821481314BQ36187349-96BF5490-0683-4EB1-B220-843402CC5F07Q36204857-835CC46B-C090-4A79-AC01-E5753829D4A1Q36214147-8A3C251F-9EB0-41F8-978F-12DFB8EA14A8Q36494604-02A597BE-2BA3-4136-AE3A-606827AB5CBDQ37348530-DED2B482-C974-41C4-8DC8-CC1E200B5F18Q38032155-024AA420-4BF5-4D70-8569-0427A36C4674Q38125279-BD3FFCD0-28B8-420E-9C59-FD27ED385DE8Q38154630-BB57B6F2-D196-4AC0-AC9F-4A3A4613A358Q38337452-24F5FAC6-4FA8-4AB4-B5DF-9AF1C66FE1F4Q38479492-940AC6E3-D87D-4A15-811A-B5A9507E105EQ38575847-F02709D8-5C75-4412-8EF9-730EA7878DBFQ38773484-5F9AA733-BF00-4BF6-BECD-B1817FA6FFA8Q38854845-492B870D-EF34-4F60-AD03-60BD406F40B3Q38890219-0AA8C95C-6513-400A-93BA-B55516783988Q39228160-5CFF9B13-70D3-4CDE-8E1A-571A7028DD1CQ41604995-7E670C0F-EA7E-4368-95D2-2DA8AC9993E3Q41694317-D2CD595F-A340-44B0-B189-C5083AED16AEQ42667861-1164E087-F38F-4BE6-AC8E-BA58C874D2DEQ46193769-962F102D-6833-4C81-8BD2-2830041E128EQ48102885-B3241F21-73F9-4137-B274-E05A58C958D7Q49194851-06AE09AC-22D7-4340-B0FC-FC2505BBC51FQ49895273-A3A69D7E-9700-4131-8DB2-FA9E882FCFAFQ50200336-7C72D4FA-EF75-4F65-95C5-7AEC203C5CFDQ52659228-BE8773EA-F1E1-46B0-A5CE-84FCD9964859
P2860
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis
@en
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis.
@nl
type
label
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis
@en
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis.
@nl
prefLabel
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis
@en
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis.
@nl
P2860
P356
P1476
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis
@en
P2093
Christian A Gleissner
P2860
P356
10.3389/FPHYS.2012.00001
P577
2012-01-13T00:00:00Z